Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study

Overview of attention for article published in Diabetes Therapy, November 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,783 followers.

Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in #Type2Diabetic Patients: A Real-life 48-Month Retrospective Study https://t.co/BU9gP3Kyeg https://t.co/9x9jHvWpgR

Reply Repost Favourite